September 05, 2025

Extended-Release Risperidone Injection Receives FDA Approval

FDA approves Amneal’s risperidone extended-release injection for schizophrenia and Bipolar I maintenance.

Conexiant

September 05, 2025

Stroke Odds Climb With Lower LE8 Scores

Modifiable lifestyle factors missing from risk prediction equations can be assessed with Life’s Essentials 8.

Conexiant

September 04, 2025

'No Standard of Care' for GLP-1 Weaning

Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates

KFF Health News

September 04, 2025

Medical Oddities: Sugar-Free, Cognition Fee?

This week: sugar-free brain costs, deadly selfies, tea for liver, knee creaks, and phone drama.

Conexiant

September 04, 2025

Study Explores Diet vs Energy Use in Obesity

Global analysis finds dietary patterns, not reduced energy expenditure, show stronger association with obesity across economic levels.

Conexiant

September 03, 2025

Study Maps Delta-Like Protein 3 and SEZ6 Across Tumor Types

Researchers highlight distinct Delta-like protein 3 and seizure-related 6 homolog patterns in neuroendocrine tumors.

Conexiant

September 02, 2025

Can AI Reliably Detect Periodontal Disease From Photos?

Artificial intelligence models are being tested for periodontal disease detection using intraoral photographs, but external validation shows performance often declines across populations and imaging devices.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

Late Dinners, Fragile Bones?

Fracture risk varies by site, with distal forearm outcomes diverging from hip, vertebral, and humeral patterns

Conexiant